Leveraging microfluidics, electroporation, and robotics, Stämm is downsizing a whole biotech plant into an all-in-one, plug-and-play desktop unit. Inspired by nature, we have developed the first methodology for continuous industrial production of biologics and cell therapies—leveraging microfluidics and 3D printing.